Alembic Ltd.
BSE: 506235 | Sector: Health care |
NSE: ALEMBICLTD | ISIN Code: INE426A01027 |
BSE 00:00 | 05 Mar | 100.60 |
-1.05 (-1.03%) |
OPEN
102.90 |
HIGH
102.90 |
LOW
100.20 |
NSE 00:00 | 05 Mar | 100.60 |
-1.15 (-1.13%) |
OPEN
102.50 |
HIGH
102.85 |
LOW
100.15 |
OPEN | 102.90 |
PREVIOUS CLOSE | 101.65 |
VOLUME | 20524 |
52-Week high | 122.75 |
52-Week low | 25.00 |
P/E | 39.61 |
Mkt Cap.(Rs cr) | 2,583 |
Buy Price | 100.60 |
Buy Qty | 50.00 |
Sell Price | 100.60 |
Sell Qty | 100.00 |
Alembic Ltd. (ALEMBICLTD) - Net Sales
Market Cap
COMPANY | LATEST(Rs) | CHG | CHG(%) | Net Sales (Rs crore) |
Aurobindo Pharma | 862.60 | -11.90 | -1.36 | 13266.48 |
Cipla | 805.45 | -0.75 | -0.09 | 12659.15 |
Sun Pharma.Inds. | 610.95 | -7.70 | -1.24 | 12531.93 |
Dr Reddy's Labs | 4489.40 | -84.90 | -1.86 | 11850.40 |
Lupin | 1031.95 | -16.20 | -1.55 | 11025.66 |
Apollo Hospitals | 2881.75 | -161.70 | -5.31 | 9794.50 |
Glenmark Pharma. | 467.90 | -6.10 | -1.29 | 6712.63 |
Alkem Lab | 2780.80 | -46.40 | -1.64 | 6677.08 |
Cadila Health. | 442.20 | -6.80 | -1.51 | 6347.40 |
Torrent Pharma. | 2483.40 | -14.40 | -0.58 | 6168.44 |
Divi's Lab. | 3495.85 | -58.45 | -1.64 | 5310.57 |
Ipca Labs. | 1925.05 | -6.10 | -0.32 | 4337.82 |
Piramal Enterp. | 1924.30 | -32.60 | -1.67 | 4219.19 |
Alembic Pharma | 916.85 | -5.15 | -0.56 | 4132.55 |
Abbott India | 14758.90 | 112.90 | 0.77 | 4093.14 |
Glaxosmi. Pharma | 1545.30 | 3.65 | 0.24 | 3224.68 |
Jubilant Pharmo | 759.40 | -24.30 | -3.10 | 3139.90 |
Sanofi India | 8237.85 | -89.05 | -1.07 | 3070.60 |
Laurus Labs | 351.30 | -17.05 | -4.63 | 2797.34 |
Gland Pharma | 2550.90 | -120.20 | -4.50 | 2633.24 |
Quick Links for Alembic:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices